Egr-1 modulation of synapsin I expression: permissive effect of forskolin via cAMP

Cellular Signalling
Allan B JamesBrian J Morris

Abstract

A number of candidate Egr-1 neuronal target genes have been identified including the synapsin I gene. Previous studies have shown that over-expression of Egr-1 in cells transfected with an Egr-1 expression vector is sufficient to activate reporter genes linked to regions of the synapsin I promoter, but any effect on the expression of synapsin I within its genomic context has not been demonstrated. We tested our hypothesis that modulation of synapsin I expression by Egr-1 requires the presence of elevated cAMP which would normally be present during periods of neuronal plasticity. Both the adenyl cyclase activator, forskolin (frsk), and the cAMP analogue, Sp-Adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt (Sp-cAMPS), enhanced the ability of Egr-1 to transactivate a CAT reporter plasmid containing multiple copies of the Egr-1 binding site (EBS). Furthermore, Egr-1 alone had minimal effects on synapsin I expression whereas forskolin treatment of PC12 cells profoundly affected the ability of Egr-1 to regulate synapsin I expression. These results suggest that Egr-1 transactivation during neuronal plasticity may rely on a permissive effect of cAMP.

References

Nov 1, 1995·Molecular and Cellular Biology·C McCoyM M Cornwell
May 16, 1994·Biochemical and Biophysical Research Communications·R P Huang, E D Adamson
Jan 7, 1993·Nature·T V Bliss, G L Collingridge
Nov 1, 1996·Brain Research. Molecular Brain Research·L A RobertsB J Morris
Feb 15, 2000·The Journal of Biological Chemistry·N R Chapman, N D Perkins
Oct 6, 2000·Biochimica Et Biophysica Acta·G ThielM Cramer
Oct 24, 2002·Brain Research. Molecular Brain Research·Brian C BondPaul Preece

❮ Previous
Next ❯

Citations

Apr 24, 2010·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Yan FanJohnny J He
Mar 16, 2007·BMC Neuroscience·Andreas R PfenningAlison L Barth
Apr 14, 2016·Pharmacology Research & Perspectives·Eimear O'NeillAndrew Harkin
Dec 23, 2009·Journal of Cellular Physiology·Silvia PegoraroVincent Torre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.